{"transactions":[{"id":2320023,"issuer":{"id":8519,"kind":"organization","name":"22nd Century Group, Inc."},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-23T17:00:12.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":124722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest 1/3 per year on March 21, 2023, 2024 and 2025, subject to continued service with the Company."}],"balance_after":124722,"source":{"system":"sec-edgar","filing":"0001567619-22-007395","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459933/000156761922007395/doc1.xml","form_type":"4"}},{"id":3013119,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-05T20:40:59.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":7681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on October 1, 2025, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":7681,"derivative":{"exercise_price":12,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":7681},"source":{"system":"sec-edgar","filing":"0001209191-20-053654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120053654/doc4.xml","form_type":"4"}},{"id":3013118,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-05T20:40:59.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":104802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":104802,"derivative":{"exercise_price":12,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":104802},"source":{"system":"sec-edgar","filing":"0001209191-20-053654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120053654/doc4.xml","form_type":"4"}},{"id":3635771,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-25T16:09:52.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":178500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 21, 2019, the reporting person was awarded options to purchase 178,500 shares of the common stock of Sesen Bio, Inc. (the \"Company\"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vesting date."}],"balance_after":178500,"derivative":{"exercise_price":0.8285,"expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":178500},"source":{"system":"sec-edgar","filing":"0001485003-19-000009","document":"wf-form4_155112897763761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500319000009/wf-form4_155112897763761.xml","form_type":"4"}},{"id":3965372,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-11T17:02:37.000Z","date":"2018-04-09","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 9, 2018, the reporting person was awarded options to purchase 200,000 shares of common stock of Eleven Biotherapeutics, Inc. (the \"Company\"), which options vest 6.25% every three months over four years, provided the reporting person is employed by the Company on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.5,"expiration_date":"2028-04-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001485003-18-000045","document":"wf-form4_152348041848084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500318000045/wf-form4_152348041848084.xml","form_type":"4"}},{"id":4089724,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":128847,"kind":"person","name":"Fitzgerald Richard F","position":1,"cik":"0001459933","reported_name":"Fitzgerald Richard F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-25T16:55:36.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option."}],"balance_after":100000,"derivative":{"exercise_price":0.93,"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001485003-18-000008","document":"wf-form4_151691732200655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500318000008/wf-form4_151691732200655.xml","form_type":"4"}}]}